The Latest Breaking News on Pharma

On Thursday, Telix Pharmaceuticals Limited (NASDAQ:TLX) received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for TLX250-CDx (Zircaix, 89Zr-DFO girentuximab), an investigational PET2 agent for the diagnosis and characterization of renal masses as clear cell renal cell carcinoma (ccRCC).

Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains.

Shares of MongoDB, Inc. (NASDAQ:MDB) rose sharply in pre-market trading after the company posted better-than-expected second-quarter results after the closing bell on Tuesday.

Some people use the drug to treat COVID, even though it’s not approved by the FDA for such use. The bill now awaits the governor’s signature.

Health secretary calls industry ‘shortsighted’ but there is danger in giving UK better terms than much of rich Europe

NovaBay Pharmaceuticals Inc. (NYSEAMERICAN: NBY) shares jumped 48.31% in after-hours trading on Tuesday, reaching $1.32 after closing the regular session at $0.89. The biotech company’s board declared a one-time special cash dividend of $0.80 per share.

It comes as a survey found almost four in 10 pharmacies are unable to pay bills for medication on time.

CORRECTION: Nvidia’s stock price in the price action section was incorrect. It has been corrected/updated.

The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical science, new therapies are emerging that promise to transform patient care and redefine market leadership in these critical areas.